title: Leukocytoclastic vasculitis drug reaction to certolizumab pegol.
abstract: Tumor necrosis factor (TNF)-alpha antagonists are a common treatment modality for autoimmune disorders, but their use can be associated with many side effects, including various dermatologic conditions. Certolizumab pegol, a newer TNF antagonist that lacks the Fc portion of the IgG antibody, has recently been approved to treat psoriatic arthritis, rheumatoid arthritis, and Crohn's disease. Though other TNF antagonists have been associated with leukocytoclastic vasculitis, this finding has not yet been reported with certolizumab pegol. We present a case report of leukocytoclastic vasculitis caused by certolizumab pegol.
authors.affiliation: University of Texas Dell Medical School, Austin, Texas (Woody); Baylor Scott & White, Marble Falls, Texas (Warren); and Westlake Dermatology, Austin, Texas (Speck, Jackson).
authors.forename: Meghan
authors.initials: M
authors.lastname: Woody
authors.affiliation: University of Texas Dell Medical School, Austin, Texas (Woody); Baylor Scott & White, Marble Falls, Texas (Warren); and Westlake Dermatology, Austin, Texas (Speck, Jackson).
authors.forename: Donald
authors.initials: D
authors.lastname: Warren
authors.affiliation: University of Texas Dell Medical School, Austin, Texas (Woody); Baylor Scott & White, Marble Falls, Texas (Warren); and Westlake Dermatology, Austin, Texas (Speck, Jackson).
authors.forename: Laura
authors.initials: L
authors.lastname: Speck
authors.affiliation: University of Texas Dell Medical School, Austin, Texas (Woody); Baylor Scott & White, Marble Falls, Texas (Warren); and Westlake Dermatology, Austin, Texas (Speck, Jackson).
authors.forename: Julie
authors.initials: J
authors.lastname: Jackson